Blood 2005,
PMID: 15705783
Tong, Wei; Zhang, Jing; Lodish, Harvey F
Erythropoietin (Epo), along with its receptor EpoR, is the principal regulator of red cell development. Upon Epo addition, the EpoR signaling through the Janus kinase 2 (JAK2) activates multiple pathways including Stat5, phosphoinositide-3 kinase (PI-3K)/Akt, and p42/44 mitogen-activated protein kinase (MAPK). The adaptor protein Lnk is implicated in cytokine receptor signaling. Here, we showed that Lnk-deficient mice have elevated numbers of erythroid progenitors, and that splenic erythroid colony-forming unit (CFU-e) progenitors are hypersensitive to Epo. Lnk(-/-) mice also exhibit superior recovery after erythropoietic stress. In addition, Lnk deficiency resulted in enhanced Epo-induced signaling pathways in splenic erythroid progenitors. Conversely, Lnk overexpression inhibits Epo-induced cell growth in 32D/EpoR cells. In primary culture of fetal liver cells, Lnk overexpression inhibits Epo-dependent erythroblast differentiation and induces apoptosis. Lnk blocks 3 major signaling pathways, Stat5, Akt, and MAPK, induced by Epo in primary erythroblasts. In addition, the Lnk Src homology 2 (SH2) domain is essential for its inhibitory function, whereas the conserved tyrosine near the C-terminus and the pleckstrin homology (PH) domain of Lnk are not critical. Furthermore, wild-type Lnk, but not the Lnk SH2 mutant, becomes tyrosine-phosphorylated following Epo administration and inhibits EpoR phosphorylation and JAK2 activation. Hence, Lnk, through its SH2 domain, negatively modulates EpoR signaling by attenuating JAK2 activation, and regulates Epo-mediated erythropoiesis.
Diseases/Pathways annotated by Medline MESH: MAP Kinase Signaling System
Document information provided by NCBI PubMed
Text Mining Data
JAK2 → Epo: "
Lnk inhibits erythropoiesis and
Epo dependent
JAK2 activation and downstream signaling pathways
"
Manually curated Databases
-
NCI Pathway Database EPO signaling pathway:
SHP1 (PTPN6)
→
EPO/EPOR (dimer) complex (EPO-EPOR)
(modification, inhibits)
Evidence: assay, other species
-
NCI Pathway Database EPO signaling pathway:
SHP1 (PTPN6)
→
LNK (SH2B3)
(modification, inhibits)
Evidence: assay, other species
-
NCI Pathway Database EPO signaling pathway:
SHP1 (PTPN6)
→
EPO/EPOR (dimer)/JAK2/SOCS3 complex (EPO-EPOR-JAK2-SOCS3)
(modification, inhibits)
Evidence: assay, other species
-
NCI Pathway Database EPO signaling pathway:
SHP1 (PTPN6)
→
EPO/EPOR (dimer)/JAK2 complex (EPO-EPOR-JAK2)
(modification, inhibits)
Evidence: assay, other species
-
NCI Pathway Database EPO signaling pathway:
SHP1 (PTPN6)
→
JAK2 (JAK2)
(modification, inhibits)
Evidence: assay, other species
-
NCI Pathway Database EPO signaling pathway:
SHP1 (PTPN6)
→
SOCS3 (SOCS3)
(modification, inhibits)
Evidence: assay, other species
-
NCI Pathway Database EPO signaling pathway:
EPO/EPOR (dimer) complex (EPO-EPOR)
→
LNK (SH2B3)
(modification, collaborate)
Evidence: assay, other species
-
NCI Pathway Database EPO signaling pathway:
EPO/EPOR (dimer) complex (EPO-EPOR)
→
EPO/EPOR (dimer)/JAK2/SOCS3 complex (EPO-EPOR-JAK2-SOCS3)
(modification, collaborate)
Evidence: assay, other species
-
NCI Pathway Database EPO signaling pathway:
EPO/EPOR (dimer) complex (EPO-EPOR)
→
EPO/EPOR (dimer)/JAK2 complex (EPO-EPOR-JAK2)
(modification, collaborate)
Evidence: assay, other species
-
NCI Pathway Database EPO signaling pathway:
EPO/EPOR (dimer) complex (EPO-EPOR)
→
JAK2 (JAK2)
(modification, collaborate)
Evidence: assay, other species
-
NCI Pathway Database EPO signaling pathway:
EPO/EPOR (dimer) complex (EPO-EPOR)
→
SOCS3 (SOCS3)
(modification, collaborate)
Evidence: assay, other species
-
NCI Pathway Database EPO signaling pathway:
LNK (SH2B3)
→
EPO/EPOR (dimer)/JAK2/SOCS3 complex (EPO-EPOR-JAK2-SOCS3)
(modification, inhibits)
Evidence: assay, other species
-
NCI Pathway Database EPO signaling pathway:
LNK (SH2B3)
→
EPO/EPOR (dimer)/JAK2 complex (EPO-EPOR-JAK2)
(modification, inhibits)
Evidence: assay, other species
-
NCI Pathway Database EPO signaling pathway:
LNK (SH2B3)
→
JAK2 (JAK2)
(modification, inhibits)
Evidence: assay, other species
-
NCI Pathway Database EPO signaling pathway:
LNK (SH2B3)
→
SOCS3 (SOCS3)
(modification, inhibits)
Evidence: assay, other species
-
NCI Pathway Database EPO signaling pathway:
EPO/EPOR (dimer)/JAK2/SOCS3 complex (EPO-EPOR-JAK2-SOCS3)
→
EPO/EPOR (dimer)/JAK2 complex (EPO-EPOR-JAK2)
(modification, collaborate)
Evidence: assay, other species
-
NCI Pathway Database EPO signaling pathway:
EPO/EPOR (dimer)/JAK2/SOCS3 complex (EPO-EPOR-JAK2-SOCS3)
→
JAK2 (JAK2)
(modification, collaborate)
Evidence: assay, other species
-
NCI Pathway Database EPO signaling pathway:
EPO/EPOR (dimer)/JAK2/SOCS3 complex (EPO-EPOR-JAK2-SOCS3)
→
SOCS3 (SOCS3)
(modification, collaborate)
Evidence: assay, other species
-
NCI Pathway Database EPO signaling pathway:
EPO/EPOR (dimer)/JAK2 complex (EPO-EPOR-JAK2)
→
JAK2 (JAK2)
(modification, collaborate)
Evidence: assay, other species
-
NCI Pathway Database EPO signaling pathway:
EPO/EPOR (dimer)/JAK2 complex (EPO-EPOR-JAK2)
→
SOCS3 (SOCS3)
(modification, collaborate)
Evidence: assay, other species
-
NCI Pathway Database EPO signaling pathway:
JAK2 (JAK2)
→
SOCS3 (SOCS3)
(modification, collaborate)
Evidence: assay, other species
In total, 19 gene pairs are associated to this article in curated databases